Description
Pirtobrutinib
Each film-coated tablet contains: Pirtobrutinib … 50 mg.
INDICATION
LuciPirto is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.
DOSAGE AND USE
The recommended dosage of LuciPirto is 200 mg orally once daily; swallow whole with water, with or without food. Do not cut, crush, or chew tablets.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children. Do not administer LuciPirto during Pregnancy and Lactation.
Reviews
There are no reviews yet.